Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Rachiglio

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Cellular Biochemistry|September 30, 2008
Leptin signaling in breast cancer: an overviewDonatella Cirillo, Anna Maria Rachiglio, Raffaele la Montagna, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 1, 2024
Transient 'NeoBRAF wild type' state in a patient with BRAF<sup>V600E</sup> mutant metastatic colorectal cancerClaudia Cardone, Sergio Facchini, Alfonso de Stefano, et al.
Critical Reviews in Eukaryotic Gene Expression|June 10, 2010
Triple negative breast cancer: from molecular portrait to therapeutic interventionPietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinomaAnna Maria Rachiglio, Alessandra Sacco, Laura Forgione, et al.
Breast Cancer Research and Treatment|December 1, 2009
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cellsAmelia D'Alessio, Antonella De Luca, Monica R Maiello, et al.
Nature Reviews. Clinical Oncology|January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Breast Cancer Research and Treatment|September 28, 2006
AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinibMonica R Maiello, Amelia D'Alessio, Antonella De Luca, et al.
International Journal of Oncology|October 6, 2011
Detection of KRAS mutations in colorectal cancer with Fast COLD-PCRPietro Carotenuto, Cristin Roma, Salvatore Cozzolino, et al.
Pharmacogenomics|August 18, 2010
Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approachPietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al.
International Journal of Molecular Sciences|September 23, 2020
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic InterventionAntonella De Luca, Riziero Esposito Abate, Anna Maria Rachiglio, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Cellular Biochemistry|September 30, 2008
Leptin signaling in breast cancer: an overviewDonatella Cirillo, Anna Maria Rachiglio, Raffaele la Montagna, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 1, 2024
Transient 'NeoBRAF wild type' state in a patient with BRAF<sup>V600E</sup> mutant metastatic colorectal cancerClaudia Cardone, Sergio Facchini, Alfonso de Stefano, et al.
Critical Reviews in Eukaryotic Gene Expression|June 10, 2010
Triple negative breast cancer: from molecular portrait to therapeutic interventionPietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinomaAnna Maria Rachiglio, Alessandra Sacco, Laura Forgione, et al.
Breast Cancer Research and Treatment|December 1, 2009
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cellsAmelia D'Alessio, Antonella De Luca, Monica R Maiello, et al.
Nature Reviews. Clinical Oncology|January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Breast Cancer Research and Treatment|September 28, 2006
AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinibMonica R Maiello, Amelia D'Alessio, Antonella De Luca, et al.
International Journal of Oncology|October 6, 2011
Detection of KRAS mutations in colorectal cancer with Fast COLD-PCRPietro Carotenuto, Cristin Roma, Salvatore Cozzolino, et al.
Pharmacogenomics|August 18, 2010
Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approachPietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al.
International Journal of Molecular Sciences|September 23, 2020
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic InterventionAntonella De Luca, Riziero Esposito Abate, Anna Maria Rachiglio, et al.
Pageof 4